Ipratropium Bromide: study card

Generic name

Ipratropium Bromide

Class

Anticholinergic (nasal)

Mechanism

Anticholinergic; applied locally, inhibits secretions from serous and seromucous nasal glands.

Used for

Symptomatic relief of rhinorrhea from a common cold or seasonal allergic rhinitis in adults and children aged 5 years and older

Common side effects

Epistaxis; Nasal dryness; Dry mouth / throat; Nasal congestion

Warnings

Hypersensitivity to atropine or derivatives (contraindicated); The 0.06% nasal solution does not relieve nasal congestion or sneezing.; Safety and effectiveness beyond four days for a cold or three weeks for seasonal allergic rhinitis have not been established.

Brand questions use only name pairings verified against the linked product source. Unverified pairings are withheld from these questions; the other study content remains available.

Label date: 20260714 · For learning, not clinical decisions. US label and brand information; always consult the current source.

Source snapshot checked: 2026-10-21. The source document and selected fields were compared. The complete card has not had an independent clinical review.